✦ LIBER ✦

Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer

✍ Scribed by Gyeong-Won Lee; Myung-Hee Kang; Hoon-Gu Kim; Jung Hun Kang; Seok Hyun Kim; Yu Ji Cho; Yi Yeong Jeong; Ho-Cheol Kim; Jong Duk Lee; Young Sil Hwang; Hye Jung Kim; Jong-Seok Lee

Publisher: Springer
Year: 2008
Tongue: English
Weight: 263 KB
Volume: 64
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0885-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic study of gemcitabine, gi

Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer

✍ Orazio Caffo; Stefania Fallani; Elena Marangon; Stefania Nobili; Maria Iris Cass 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 171 KB

Combination of low-dose cisplatin and ge

Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

✍ J. Feliu; G. Martín; C. Madroñal; A. Rodríguez-Jaráiz; J. Castro; A Rodríguez; T 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 189 KB

Non-platinum doublets versus single agen

Non-platinum doublets versus single agents in non-small cell lung cancer (NSCLC) patients with elderly age and/or poor performance status: a meta-analysis

✍ Huijuan Qiu; Fang Wang; Guifang Guo; Feifei Zhou; Wenzhuo He; Liangping Xia 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 556 KB

Weekly docetaxel versus docetaxel/gemcit

Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer : A randomized phase 3 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; David R. Spigel; Cindy Farley; Dianna L. Shipley; James D. B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

## Abstract ## BACKGROUND. The aim of this study was to compare the efficacy of single‐agent weekly docetaxel with the combination of docetaxel and gemcitabine in elderly and/or poor performance status patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Previously untreated pat

Phase I/II study of weekly docetaxel dos

Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer

✍ Nobuyuki Yamamoto; Yasumasa Nishimura; Kazuhiko Nakagawa; Kaoru Matsui; Masahiro 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 258 KB

The efficacy and relationship between pe

The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer

✍ Linrun Wang; Xiuhua Wu; Mingzhu Huang; Jie Cai; Nong Xu; Jian Liu 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 234 KB